UBS ASSET MANAGEMENT AMERICAS INC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$3,560,065
-12.4%
120,844
+4.6%
0.00%0.0%
Q2 2023$4,066,0640.0%115,5460.0%0.00%0.0%
Q1 2023$4,066,064
-8.8%
115,546
+18.8%
0.00%0.0%
Q4 2022$4,457,921
-99.9%
97,292
+19.0%
0.00%0.0%
Q3 2022$3,962,193,000
+1.4%
81,779
-17.8%
0.00%0.0%
Q2 2022$3,907,391,000
+13.4%
99,450
+6.2%
0.00%
+100.0%
Q1 2022$3,446,998,000
-19.7%
93,643
-0.6%
0.00%
-50.0%
Q4 2021$4,292,178,000
+73.0%
94,168
+35.7%
0.00%
+100.0%
Q3 2021$2,480,713,000
+99.2%
69,410
+10.3%
0.00%0.0%
Q2 2021$1,245,483,000
-15.6%
62,935
-0.8%
0.00%0.0%
Q1 2021$1,475,079,000
+32.5%
63,417
+18.4%
0.00%0.0%
Q4 2020$1,113,288,000
-2.8%
53,575
+1.2%
0.00%0.0%
Q3 2020$1,145,891,000
+0.4%
52,928
+9.3%
0.00%0.0%
Q2 2020$1,140,999,000
+63.0%
48,409
-18.4%
0.00%0.0%
Q1 2020$699,867,000
+41.3%
59,361
+27.2%
0.00%
Q4 2019$495,286,000
-24.9%
46,681
-19.5%
0.00%
Q3 2019$659,722,000
+102.0%
57,972
+99.7%
0.00%
Q2 2019$326,520,000
+39.1%
29,0240.0%0.00%
Q1 2019$234,804,000
+41.8%
29,024
+10.8%
0.00%
Q4 2018$165,584,000
-35.8%
26,2000.0%0.00%
Q3 2018$258,070,000
+18.7%
26,2000.0%0.00%
Q2 2018$217,460,00026,2000.00%
Other shareholders
CYTOKINETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders